Vehiculum Capital

Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.

Prosper specializes in wealth management for high-net-worth individuals. It offers a platform providing access to publicly traded investment funds, high-yield cash savings products, financial guidance, and private market funds, all designed to help clients maximize their wealth.

Invitris is a biotech company focused on developing protein-based drugs and manufacturing bacteriophages to combat antibiotic-resistant bacteria. The company specializes in synthesizing arbitrary phages within a single system, which allows for effective quality assessment, synthetic phage production, and quality control services. By enabling personalized diagnostics, Invitris aims to provide patients with targeted treatments for bacterial infections, ensuring both safety and practical application in the fight against resistant pathogens.

ChipFlow is an open-source platform for semiconductor chip design. It offers automated integrated circuit layout using artificial intelligence, streamlining the process from design to manufacturing and shipping, particularly suited for low-volume orders.